infezioni polmonari: gestione diversa per hap & vap · – ppi ? – diuretics ? 3 sorelle ???...
TRANSCRIPT
![Page 1: Infezioni polmonari: gestione diversa per HAP & VAP · – PPI ? – Diuretics ? 3 sorelle ??? ... marmellata di albicocca) INFECTIONS & AMS in ICU ID in ICU ? INFECTIONS & AMS in](https://reader030.vdocuments.net/reader030/viewer/2022040720/5e2c95b3399b0361fd676b5e/html5/thumbnails/1.jpg)
Infezioni polmonari: gestione diversa per HAP & VAP ?
Massimo Girardis
Gruppo di studio SIAARTI
Infezioni e Sepsi in Terapia Intensiva
![Page 2: Infezioni polmonari: gestione diversa per HAP & VAP · – PPI ? – Diuretics ? 3 sorelle ??? ... marmellata di albicocca) INFECTIONS & AMS in ICU ID in ICU ? INFECTIONS & AMS in](https://reader030.vdocuments.net/reader030/viewer/2022040720/5e2c95b3399b0361fd676b5e/html5/thumbnails/2.jpg)
The panel unanimously decided that HCAP should not be included in the HAP/VAP guidelines.
It was thought that this could be included in the upcoming CAP guidelines because patients with HCAP frequently present from the community and are initially cared for in emergency departments.
There is increasing evidence that many patients defined as having HCAP are not at high risk for MDR pathogens
Recommendations regarding coverage for MDR pathogens among HCAP who develop pneumonia would likely be based on validated risk factors
![Page 3: Infezioni polmonari: gestione diversa per HAP & VAP · – PPI ? – Diuretics ? 3 sorelle ??? ... marmellata di albicocca) INFECTIONS & AMS in ICU ID in ICU ? INFECTIONS & AMS in](https://reader030.vdocuments.net/reader030/viewer/2022040720/5e2c95b3399b0361fd676b5e/html5/thumbnails/3.jpg)
EARLY
LATE
![Page 4: Infezioni polmonari: gestione diversa per HAP & VAP · – PPI ? – Diuretics ? 3 sorelle ??? ... marmellata di albicocca) INFECTIONS & AMS in ICU ID in ICU ? INFECTIONS & AMS in](https://reader030.vdocuments.net/reader030/viewer/2022040720/5e2c95b3399b0361fd676b5e/html5/thumbnails/4.jpg)
INFECTIONS & AMS is an issue in ICU ?
Epidemiology - Difficult Infections
Data from infection section - adult population
YEAR 2013 - 162 ICUs- N = 53776
O Patients infected at admission: 19,0%
O Pneumonia 38% (HAP 40 %) O MDR Gram Pos 13 %, Gram Neg 26 %, Res Carba 15%
O Shock 25%, Sepsi grave 37%, Batteriemica 12%
O Mortalità TI 28%, H 38%
O Patients infected during stay: 8,1%
O Pneumonia 39% (VAP 85%) O MDR Gram Pos 13 % MDR Gram Neg 30 % Res Carba 19%
O Batteriemica 21 %
O Mortalità TI 27%, H 32%
![Page 5: Infezioni polmonari: gestione diversa per HAP & VAP · – PPI ? – Diuretics ? 3 sorelle ??? ... marmellata di albicocca) INFECTIONS & AMS in ICU ID in ICU ? INFECTIONS & AMS in](https://reader030.vdocuments.net/reader030/viewer/2022040720/5e2c95b3399b0361fd676b5e/html5/thumbnails/5.jpg)
Study/Dbase: HELICS (study BURDEN) Population: 119699 ICU patients (> 2 days), 2005-2008, 537 ICUs (Spain France, Austria, Other Europe Results: • Incidence: HAP 8525 (7%), VAP 7675 (90% of HAP) • Microorganisms Ps. Aeur. 20,2% (I/R 22%); Staph Aur. 18, 2% (MRSA 34%) E.coli 7,8% (I/R 11%) A. Baum. 5,9% (I/R 75%)
• HAP/VAP x 2 risk of ICU mortality • MDR low effect on ICU mortality
![Page 6: Infezioni polmonari: gestione diversa per HAP & VAP · – PPI ? – Diuretics ? 3 sorelle ??? ... marmellata di albicocca) INFECTIONS & AMS in ICU ID in ICU ? INFECTIONS & AMS in](https://reader030.vdocuments.net/reader030/viewer/2022040720/5e2c95b3399b0361fd676b5e/html5/thumbnails/6.jpg)
1. Individual patient data for 6284 patients from 24 trials.
2. Attributable mortality was close to zero in trauma, medical patients, and patients with low or high severity of illness scores.
3. The overall attributable mortality was 13%, with higher mortality rates in surgical patients and patients with mid-range severity scores at admission
![Page 7: Infezioni polmonari: gestione diversa per HAP & VAP · – PPI ? – Diuretics ? 3 sorelle ??? ... marmellata di albicocca) INFECTIONS & AMS in ICU ID in ICU ? INFECTIONS & AMS in](https://reader030.vdocuments.net/reader030/viewer/2022040720/5e2c95b3399b0361fd676b5e/html5/thumbnails/7.jpg)
Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society
In Patients With Suspected HAP/VAP, to Decide Whether or Not to Initiate
Antibiotic Therapy:
- PCT Plus Clinical Criteria
- CRP Plus Clinical Criteria
- sTREM-1 Plus Clinical Criteria
- CPIS Plus Clinical Criteria
- Clinical Criteria Alone
For patients with suspected HAP/VAP, we recommend using clinical criteria alone rather than Biomarkers or Scores
![Page 8: Infezioni polmonari: gestione diversa per HAP & VAP · – PPI ? – Diuretics ? 3 sorelle ??? ... marmellata di albicocca) INFECTIONS & AMS in ICU ID in ICU ? INFECTIONS & AMS in](https://reader030.vdocuments.net/reader030/viewer/2022040720/5e2c95b3399b0361fd676b5e/html5/thumbnails/8.jpg)
Should Patients With Suspected VAP Be Treated Based on the Results a)Invasive Sampling (ie, Bronchoscopy, Blind Bronchial Sampling) With Quantitative
Culture Results, b)Noninvasive Sampling (ie, Endotracheal Aspiration) With Quantitative Culture
Results, c) Noninvasive Sampling With Semiquantitative Culture Results
Should Patients With Suspected HAP Be Treated Based on the Results of Microbiologic Studies Performed on Respiratory Samples, or Should Treatment Be Empiric?
We suggest noninvasive sampling with semiquantitative cultures to diagnose VAP, rather than invasive sampling with quantitative cultures and rather than noninvasive sampling with quantitative cultures (weak recommendation, low-quality evidence).
We suggest that patients with suspected HAP (non-VAP) be treated according to the results of microbiologic studies performed on respiratory samples obtained noninvasively (spontaneous expectoration, sputum induction, nasotracheal suctioning) (weak recommendation, very low-quality evidence).
Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society
![Page 9: Infezioni polmonari: gestione diversa per HAP & VAP · – PPI ? – Diuretics ? 3 sorelle ??? ... marmellata di albicocca) INFECTIONS & AMS in ICU ID in ICU ? INFECTIONS & AMS in](https://reader030.vdocuments.net/reader030/viewer/2022040720/5e2c95b3399b0361fd676b5e/html5/thumbnails/9.jpg)
![Page 10: Infezioni polmonari: gestione diversa per HAP & VAP · – PPI ? – Diuretics ? 3 sorelle ??? ... marmellata di albicocca) INFECTIONS & AMS in ICU ID in ICU ? INFECTIONS & AMS in](https://reader030.vdocuments.net/reader030/viewer/2022040720/5e2c95b3399b0361fd676b5e/html5/thumbnails/10.jpg)
Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society
In patients with suspected VAP, we recommend including coverage for S. aureus, Pseudomonas aeruginosa, and other gram-negative bacilli in all empiric regimens (strong recommendation, low-quality evidence).
When MRSA a) Risk factor b) units where >10%–20% of S.
aureus isolates are methicillin resistant.
c) patients in units where the prevalence of MRSA is not
When 2 Abx Anti-Pseudo a) Risk factor b) units >10% of gram-negative
isolates are resistant to an agent considered for monotherapy,
c) local antimicrobial susceptibility rates are not available
![Page 11: Infezioni polmonari: gestione diversa per HAP & VAP · – PPI ? – Diuretics ? 3 sorelle ??? ... marmellata di albicocca) INFECTIONS & AMS in ICU ID in ICU ? INFECTIONS & AMS in](https://reader030.vdocuments.net/reader030/viewer/2022040720/5e2c95b3399b0361fd676b5e/html5/thumbnails/11.jpg)
Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society
![Page 12: Infezioni polmonari: gestione diversa per HAP & VAP · – PPI ? – Diuretics ? 3 sorelle ??? ... marmellata di albicocca) INFECTIONS & AMS in ICU ID in ICU ? INFECTIONS & AMS in](https://reader030.vdocuments.net/reader030/viewer/2022040720/5e2c95b3399b0361fd676b5e/html5/thumbnails/12.jpg)
Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society
In patients with suspected HAP, we recommend including coverage for S. aureus (strong recommendation, low-quality evidence).
When MRSA a) Risk factor b) units where >10%–20% of S.
aureus isolates are methicillin resistant.
c) patients in units where the prevalence of MRSA is not
For patients with HAP who are being treated empirically, we recommend prescribing antibiotics with activity against P. aeruginosa and other gram-negative bacilli (strong recommendation, very low-quality evidence).
When 2 AntiPseudo a) Risk factor MDR HAP b) High risk Mortality: Shock or
mechanically ventialted
![Page 13: Infezioni polmonari: gestione diversa per HAP & VAP · – PPI ? – Diuretics ? 3 sorelle ??? ... marmellata di albicocca) INFECTIONS & AMS in ICU ID in ICU ? INFECTIONS & AMS in](https://reader030.vdocuments.net/reader030/viewer/2022040720/5e2c95b3399b0361fd676b5e/html5/thumbnails/13.jpg)
Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society
![Page 14: Infezioni polmonari: gestione diversa per HAP & VAP · – PPI ? – Diuretics ? 3 sorelle ??? ... marmellata di albicocca) INFECTIONS & AMS in ICU ID in ICU ? INFECTIONS & AMS in](https://reader030.vdocuments.net/reader030/viewer/2022040720/5e2c95b3399b0361fd676b5e/html5/thumbnails/14.jpg)
Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society
![Page 15: Infezioni polmonari: gestione diversa per HAP & VAP · – PPI ? – Diuretics ? 3 sorelle ??? ... marmellata di albicocca) INFECTIONS & AMS in ICU ID in ICU ? INFECTIONS & AMS in](https://reader030.vdocuments.net/reader030/viewer/2022040720/5e2c95b3399b0361fd676b5e/html5/thumbnails/15.jpg)
INFECTIONS & AMS in ICU
Methods in ICU
O PCT guided prescribing: O Reduces antibiotic usage when used as a de-escalation/stop trigger
without increase of mortality O Does not improve outcomes when used as an escalation trigger alone
![Page 16: Infezioni polmonari: gestione diversa per HAP & VAP · – PPI ? – Diuretics ? 3 sorelle ??? ... marmellata di albicocca) INFECTIONS & AMS in ICU ID in ICU ? INFECTIONS & AMS in](https://reader030.vdocuments.net/reader030/viewer/2022040720/5e2c95b3399b0361fd676b5e/html5/thumbnails/16.jpg)
Study/Dbase: IMPACT-HAP (US 4 University Hospitals Population: 413 ICU patients with pneumonia pre-after implementation program (2006-2007) 303/413 (73%) at risk for MDR 174/303 (57%) no compliant guidelines
![Page 17: Infezioni polmonari: gestione diversa per HAP & VAP · – PPI ? – Diuretics ? 3 sorelle ??? ... marmellata di albicocca) INFECTIONS & AMS in ICU ID in ICU ? INFECTIONS & AMS in](https://reader030.vdocuments.net/reader030/viewer/2022040720/5e2c95b3399b0361fd676b5e/html5/thumbnails/17.jpg)
![Page 18: Infezioni polmonari: gestione diversa per HAP & VAP · – PPI ? – Diuretics ? 3 sorelle ??? ... marmellata di albicocca) INFECTIONS & AMS in ICU ID in ICU ? INFECTIONS & AMS in](https://reader030.vdocuments.net/reader030/viewer/2022040720/5e2c95b3399b0361fd676b5e/html5/thumbnails/18.jpg)
Infezioni polmonari: gestione diversa per HAP & VAP ?
TAKE HOME PICTURE
![Page 19: Infezioni polmonari: gestione diversa per HAP & VAP · – PPI ? – Diuretics ? 3 sorelle ??? ... marmellata di albicocca) INFECTIONS & AMS in ICU ID in ICU ? INFECTIONS & AMS in](https://reader030.vdocuments.net/reader030/viewer/2022040720/5e2c95b3399b0361fd676b5e/html5/thumbnails/19.jpg)
INFECTIONS & AMS is an issue in ICU ?
Use of Antibiotics
O ICU interventions - TOP 5 (% patients)
1. Antibiotics 75,4% Prophylaxis 49%
Empiric 25%
Targeted 16%
2. MV 72,9%
3. Parenteral nutrition 38,3%
4. Vasoactive drugs 35,9%
5. Enteral nutrition 30,1%
Data from adult population with ICU admission ≥ 24 hours
YEAR 2013 - 178 ICUs- N = 34262
Maybe also :
– Oxygen ?
– Fluids ?
– PPI ?
– Diuretics ?
![Page 20: Infezioni polmonari: gestione diversa per HAP & VAP · – PPI ? – Diuretics ? 3 sorelle ??? ... marmellata di albicocca) INFECTIONS & AMS in ICU ID in ICU ? INFECTIONS & AMS in](https://reader030.vdocuments.net/reader030/viewer/2022040720/5e2c95b3399b0361fd676b5e/html5/thumbnails/20.jpg)
3 sorelle ???
![Page 21: Infezioni polmonari: gestione diversa per HAP & VAP · – PPI ? – Diuretics ? 3 sorelle ??? ... marmellata di albicocca) INFECTIONS & AMS in ICU ID in ICU ? INFECTIONS & AMS in](https://reader030.vdocuments.net/reader030/viewer/2022040720/5e2c95b3399b0361fd676b5e/html5/thumbnails/21.jpg)
INFECTIONS & AMS is an issue in ICU ?
Empiric Antibiotic Therapy ? Clinical
Signs Clinical history (Community-Nosocomial)
Source (s) infection
Micro-organisms epidemiology Organ dysfunction (s)
(liver –kidney)
PK/PD
RCT EBM
Manage ICU Abx resistances
![Page 22: Infezioni polmonari: gestione diversa per HAP & VAP · – PPI ? – Diuretics ? 3 sorelle ??? ... marmellata di albicocca) INFECTIONS & AMS in ICU ID in ICU ? INFECTIONS & AMS in](https://reader030.vdocuments.net/reader030/viewer/2022040720/5e2c95b3399b0361fd676b5e/html5/thumbnails/22.jpg)
INFECTIONS & AMS is an issue in ICU ?
Empiric Antibiotic Therapy and Outcome
i. Time ii. Molecule iii. Dose
![Page 23: Infezioni polmonari: gestione diversa per HAP & VAP · – PPI ? – Diuretics ? 3 sorelle ??? ... marmellata di albicocca) INFECTIONS & AMS in ICU ID in ICU ? INFECTIONS & AMS in](https://reader030.vdocuments.net/reader030/viewer/2022040720/5e2c95b3399b0361fd676b5e/html5/thumbnails/23.jpg)
INFECTIONS & AMS is an issue in ICU ?
Antibiotic Dose ?
O Prospective, 68 ICUs; β-lactam blood concentration
O 361 patients 69%/31% infection/prophylaxis; 67%/33% bolus /continuous
O High variability
O 50% fT > MIC: • 80% of patients bolus • 93% of continuous
O In the 16% patients without 50% fT > MIC reduced probability of positive outcome (OR 0,68 CI 0,51-0,91)
End-dose interval
![Page 24: Infezioni polmonari: gestione diversa per HAP & VAP · – PPI ? – Diuretics ? 3 sorelle ??? ... marmellata di albicocca) INFECTIONS & AMS in ICU ID in ICU ? INFECTIONS & AMS in](https://reader030.vdocuments.net/reader030/viewer/2022040720/5e2c95b3399b0361fd676b5e/html5/thumbnails/24.jpg)
INFECTIONS & AMS is an issue in ICU ?
Intensivist: which education in AMS?
O Graduate Program ?
O Residence Program ?
O Post-graduate education (congress, courses) ? O SIAARTI 2014 ~ 5% of lectures, no PG course
O ESICM 2014 ~ 8% of lectures, no PG course
O ISICEM 2015 ~ 10% of lectures (majority sponsored), no PG course
O SMART 2015 ~ 3% of lectures, 1 PG course
![Page 25: Infezioni polmonari: gestione diversa per HAP & VAP · – PPI ? – Diuretics ? 3 sorelle ??? ... marmellata di albicocca) INFECTIONS & AMS in ICU ID in ICU ? INFECTIONS & AMS in](https://reader030.vdocuments.net/reader030/viewer/2022040720/5e2c95b3399b0361fd676b5e/html5/thumbnails/25.jpg)
INFECTIONS & AMS in ICU
Sepsis Stewardship Programs Mortality = ES 0,66 (0,61-0,72)
![Page 26: Infezioni polmonari: gestione diversa per HAP & VAP · – PPI ? – Diuretics ? 3 sorelle ??? ... marmellata di albicocca) INFECTIONS & AMS in ICU ID in ICU ? INFECTIONS & AMS in](https://reader030.vdocuments.net/reader030/viewer/2022040720/5e2c95b3399b0361fd676b5e/html5/thumbnails/26.jpg)
INFECTIONS & AMS in ICU
How to face with ?
O Survey 2011, questionnaire, 175 ICUs
![Page 27: Infezioni polmonari: gestione diversa per HAP & VAP · – PPI ? – Diuretics ? 3 sorelle ??? ... marmellata di albicocca) INFECTIONS & AMS in ICU ID in ICU ? INFECTIONS & AMS in](https://reader030.vdocuments.net/reader030/viewer/2022040720/5e2c95b3399b0361fd676b5e/html5/thumbnails/27.jpg)
INFECTIONS & AMS in ICU
ID in ICU
![Page 28: Infezioni polmonari: gestione diversa per HAP & VAP · – PPI ? – Diuretics ? 3 sorelle ??? ... marmellata di albicocca) INFECTIONS & AMS in ICU ID in ICU ? INFECTIONS & AMS in](https://reader030.vdocuments.net/reader030/viewer/2022040720/5e2c95b3399b0361fd676b5e/html5/thumbnails/28.jpg)
INFECTIONS & AMS in ICU
ID in ICU
O Medical ICU, 3 months pre-post, 264 patients O Appropriateness of AbTX: 63% -> 88%
O DDD reduction O Overall (- 12%) O Pip/Tazo (-5%) O Vanco & Linezolid (-
5%), O Metro (-91%) O Carba (-41%)
O Reduction of MV days: 10-> 6 days O Reduction of ICU LOS: 11-> 8 days O Reduction of H mortality (no ICU) 37% ->24%
![Page 29: Infezioni polmonari: gestione diversa per HAP & VAP · – PPI ? – Diuretics ? 3 sorelle ??? ... marmellata di albicocca) INFECTIONS & AMS in ICU ID in ICU ? INFECTIONS & AMS in](https://reader030.vdocuments.net/reader030/viewer/2022040720/5e2c95b3399b0361fd676b5e/html5/thumbnails/29.jpg)
10 DOTI NECESSARIE 1. Deve sapere cosa è un paziente critico 2. Deve sapere quali farmaci sono usati (interazione), volumi di
distribuzione pazienti con shock , come funziona CRRT. 3. Deve fare un pezzo della sua vita clinica con noi (non veni-vidi-
prescriba). Non può essere ogni settimana diverso 4. Deve rispondere al telefono sempre quando vede il numero della ICU
(è urgente) 5. Deve condividere le scelte etiche, i successi e gli insuccessi (anche con
i parenti) 6. Deve essere coinvolto-responsabile nella gestione del budget 7. Deve sapere usare leadership ma anche fellowship 8. Deve provvedere e seguire protocolli uguali per le condzioni
‘standard’ per non creare s.me del druido (e della pozione magica) 9. Deve tenere la contabilità delle infezioni e delle resistenze. 10. Deve portare le brioche calde al giro del mattino (meglio alla
marmellata di albicocca)
INFECTIONS & AMS in ICU ID in ICU ?
![Page 30: Infezioni polmonari: gestione diversa per HAP & VAP · – PPI ? – Diuretics ? 3 sorelle ??? ... marmellata di albicocca) INFECTIONS & AMS in ICU ID in ICU ? INFECTIONS & AMS in](https://reader030.vdocuments.net/reader030/viewer/2022040720/5e2c95b3399b0361fd676b5e/html5/thumbnails/30.jpg)
INFECTIONS & AMS in ICU
ID in ICU ?
![Page 31: Infezioni polmonari: gestione diversa per HAP & VAP · – PPI ? – Diuretics ? 3 sorelle ??? ... marmellata di albicocca) INFECTIONS & AMS in ICU ID in ICU ? INFECTIONS & AMS in](https://reader030.vdocuments.net/reader030/viewer/2022040720/5e2c95b3399b0361fd676b5e/html5/thumbnails/31.jpg)
TAKE HOME PICTURE
![Page 32: Infezioni polmonari: gestione diversa per HAP & VAP · – PPI ? – Diuretics ? 3 sorelle ??? ... marmellata di albicocca) INFECTIONS & AMS in ICU ID in ICU ? INFECTIONS & AMS in](https://reader030.vdocuments.net/reader030/viewer/2022040720/5e2c95b3399b0361fd676b5e/html5/thumbnails/32.jpg)
INFECTIONS & AMS is an issue in ICU ?
How to face with ?
O Survey 2011, 175 ICUs questionnaire
![Page 33: Infezioni polmonari: gestione diversa per HAP & VAP · – PPI ? – Diuretics ? 3 sorelle ??? ... marmellata di albicocca) INFECTIONS & AMS in ICU ID in ICU ? INFECTIONS & AMS in](https://reader030.vdocuments.net/reader030/viewer/2022040720/5e2c95b3399b0361fd676b5e/html5/thumbnails/33.jpg)
OBIETTIVO: Rispondere a 3 domande:
COSA (definzioni ed indicatori) ENTITA’ (quanto e qualità) EFFETTO – CLINICA (outcome, gestione clinica)
PROBLEMI Gran parte studi sono volontari senza QUALY-control
Popolazione e definizioni eterogenee (specialmente per HCAP)
Pochi studi interventistici….
Studi interventistici (Ab Terapia) sono osservazionali, retrospettivi e pre/post (livello II-III)
![Page 34: Infezioni polmonari: gestione diversa per HAP & VAP · – PPI ? – Diuretics ? 3 sorelle ??? ... marmellata di albicocca) INFECTIONS & AMS in ICU ID in ICU ? INFECTIONS & AMS in](https://reader030.vdocuments.net/reader030/viewer/2022040720/5e2c95b3399b0361fd676b5e/html5/thumbnails/34.jpg)
3147 patients (>24 H), 198 EU ICUs
1-15 May 2002
No Sepsis 1970 (60%), H mort 17%
Sepsis 1177 (40%), H mort 36%
25%
![Page 35: Infezioni polmonari: gestione diversa per HAP & VAP · – PPI ? – Diuretics ? 3 sorelle ??? ... marmellata di albicocca) INFECTIONS & AMS in ICU ID in ICU ? INFECTIONS & AMS in](https://reader030.vdocuments.net/reader030/viewer/2022040720/5e2c95b3399b0361fd676b5e/html5/thumbnails/35.jpg)
Microbiology: - Enterboacteriaceae (E.coli, Kleb, Proteus, Serratia) most common, then Staph Aur , Ps Ae - High incidence of A. baumannii. - No differences between HAP and VAP
*
*
![Page 36: Infezioni polmonari: gestione diversa per HAP & VAP · – PPI ? – Diuretics ? 3 sorelle ??? ... marmellata di albicocca) INFECTIONS & AMS in ICU ID in ICU ? INFECTIONS & AMS in](https://reader030.vdocuments.net/reader030/viewer/2022040720/5e2c95b3399b0361fd676b5e/html5/thumbnails/36.jpg)
Microbiology EARLY vs LATE VAP:
- MORE MSSA, H. Influ, Strep Pn
- LESS Ps Aeur, A. Baumannii
- LESS High risk organism
* *
Microbiology Country Staph Aur e Ps. Aeur more frequent 1° 2° High incidence A.Baum in Greece and Turkey E.coli frequent Germany and Belgium
![Page 37: Infezioni polmonari: gestione diversa per HAP & VAP · – PPI ? – Diuretics ? 3 sorelle ??? ... marmellata di albicocca) INFECTIONS & AMS in ICU ID in ICU ? INFECTIONS & AMS in](https://reader030.vdocuments.net/reader030/viewer/2022040720/5e2c95b3399b0361fd676b5e/html5/thumbnails/37.jpg)
Study/Dbase: EU-VAP/CAP
Population: 2436 ICU patients (> 2 days and
ventilated), 27 ICUs from 9 EU countries
Results:
• VAP:
•Trauma 128/354, 36%
•No trauma 337/2082, 16%,
• ICU Mortality:
•Trauma 22/128, 17%
•No Trauma 142/337, 43%
• Micro-organism:
• Trauma early (67): 74% No resistant bacteria
• Trauma late (64): 37% No resistant bacteria
![Page 38: Infezioni polmonari: gestione diversa per HAP & VAP · – PPI ? – Diuretics ? 3 sorelle ??? ... marmellata di albicocca) INFECTIONS & AMS in ICU ID in ICU ? INFECTIONS & AMS in](https://reader030.vdocuments.net/reader030/viewer/2022040720/5e2c95b3399b0361fd676b5e/html5/thumbnails/38.jpg)
Collaborative Italian Group
for Intensive Care Unit Vigilance
GiVITI 2009
Project “Margherita”
![Page 39: Infezioni polmonari: gestione diversa per HAP & VAP · – PPI ? – Diuretics ? 3 sorelle ??? ... marmellata di albicocca) INFECTIONS & AMS in ICU ID in ICU ? INFECTIONS & AMS in](https://reader030.vdocuments.net/reader030/viewer/2022040720/5e2c95b3399b0361fd676b5e/html5/thumbnails/39.jpg)
Collaborative Italian Group for Intensive Care Unit Vigilance
GiVITI 2009
![Page 40: Infezioni polmonari: gestione diversa per HAP & VAP · – PPI ? – Diuretics ? 3 sorelle ??? ... marmellata di albicocca) INFECTIONS & AMS in ICU ID in ICU ? INFECTIONS & AMS in](https://reader030.vdocuments.net/reader030/viewer/2022040720/5e2c95b3399b0361fd676b5e/html5/thumbnails/40.jpg)
Collaborative Italian Group for Intensive Care Unit Vigilance
GiVITI 2009
> 4 gg
Polmonite associata a ventilazione meccanica invasiva, da + 2 gg inizio a + 2 gg dopo
![Page 41: Infezioni polmonari: gestione diversa per HAP & VAP · – PPI ? – Diuretics ? 3 sorelle ??? ... marmellata di albicocca) INFECTIONS & AMS in ICU ID in ICU ? INFECTIONS & AMS in](https://reader030.vdocuments.net/reader030/viewer/2022040720/5e2c95b3399b0361fd676b5e/html5/thumbnails/41.jpg)
Collaborative Italian Group for Intensive Care Unit Vigilance
GiVITI 2009
38
44
70
23 50
41 46
![Page 42: Infezioni polmonari: gestione diversa per HAP & VAP · – PPI ? – Diuretics ? 3 sorelle ??? ... marmellata di albicocca) INFECTIONS & AMS in ICU ID in ICU ? INFECTIONS & AMS in](https://reader030.vdocuments.net/reader030/viewer/2022040720/5e2c95b3399b0361fd676b5e/html5/thumbnails/42.jpg)
Definizione Originale
+
![Page 43: Infezioni polmonari: gestione diversa per HAP & VAP · – PPI ? – Diuretics ? 3 sorelle ??? ... marmellata di albicocca) INFECTIONS & AMS in ICU ID in ICU ? INFECTIONS & AMS in](https://reader030.vdocuments.net/reader030/viewer/2022040720/5e2c95b3399b0361fd676b5e/html5/thumbnails/43.jpg)
CAP H-CAP HAP VAP
Kollef 2005 59 US Hospitals 4543 patients with culture positive pneumonia in H in the first 5 days (2002-2003)
49% 22% 18% 11%
Carratalà 2007
1 Spanish Hospital 727 patients with pneumonia in ED (2001-2004)
83% 17%
Micek 2007
1 US Hospital 639 patients with culture positive in ED (2003-2005) (HCAP ATS criteria + 12 months hospitalization+ immunsup.)
33% 67%
Venditti 2009
55 Italian Hospitals 59 Medical divisions 362 patients with pneumonia (1 week January + 1 week July 2007)
61% 25% 24%
![Page 44: Infezioni polmonari: gestione diversa per HAP & VAP · – PPI ? – Diuretics ? 3 sorelle ??? ... marmellata di albicocca) INFECTIONS & AMS in ICU ID in ICU ? INFECTIONS & AMS in](https://reader030.vdocuments.net/reader030/viewer/2022040720/5e2c95b3399b0361fd676b5e/html5/thumbnails/44.jpg)
• Più anziani vs CAP • Più co-morbidità vs CAP • Più Score gravità polmonite vs CAP • Più ricoveri ICU vs CAP • Più mortalità vs CAP
![Page 45: Infezioni polmonari: gestione diversa per HAP & VAP · – PPI ? – Diuretics ? 3 sorelle ??? ... marmellata di albicocca) INFECTIONS & AMS in ICU ID in ICU ? INFECTIONS & AMS in](https://reader030.vdocuments.net/reader030/viewer/2022040720/5e2c95b3399b0361fd676b5e/html5/thumbnails/45.jpg)
Differenze tra studi determinate da differenze popolazione e disegno
![Page 46: Infezioni polmonari: gestione diversa per HAP & VAP · – PPI ? – Diuretics ? 3 sorelle ??? ... marmellata di albicocca) INFECTIONS & AMS in ICU ID in ICU ? INFECTIONS & AMS in](https://reader030.vdocuments.net/reader030/viewer/2022040720/5e2c95b3399b0361fd676b5e/html5/thumbnails/46.jpg)
3 sorelle ???
![Page 47: Infezioni polmonari: gestione diversa per HAP & VAP · – PPI ? – Diuretics ? 3 sorelle ??? ... marmellata di albicocca) INFECTIONS & AMS in ICU ID in ICU ? INFECTIONS & AMS in](https://reader030.vdocuments.net/reader030/viewer/2022040720/5e2c95b3399b0361fd676b5e/html5/thumbnails/47.jpg)
Collaborative Italian Group
for Intensive Care Unit Vigilance
GiVITI 2009
Project “Margherita”
![Page 48: Infezioni polmonari: gestione diversa per HAP & VAP · – PPI ? – Diuretics ? 3 sorelle ??? ... marmellata di albicocca) INFECTIONS & AMS in ICU ID in ICU ? INFECTIONS & AMS in](https://reader030.vdocuments.net/reader030/viewer/2022040720/5e2c95b3399b0361fd676b5e/html5/thumbnails/48.jpg)
Collaborative Italian Group for Intensive Care Unit Vigilance
GiVITI 2009
![Page 49: Infezioni polmonari: gestione diversa per HAP & VAP · – PPI ? – Diuretics ? 3 sorelle ??? ... marmellata di albicocca) INFECTIONS & AMS in ICU ID in ICU ? INFECTIONS & AMS in](https://reader030.vdocuments.net/reader030/viewer/2022040720/5e2c95b3399b0361fd676b5e/html5/thumbnails/49.jpg)
Collaborative Italian Group for Intensive Care Unit Vigilance
GiVITI 2009
0,45 0,66
0,56 0,29 0,57
0,57
![Page 50: Infezioni polmonari: gestione diversa per HAP & VAP · – PPI ? – Diuretics ? 3 sorelle ??? ... marmellata di albicocca) INFECTIONS & AMS in ICU ID in ICU ? INFECTIONS & AMS in](https://reader030.vdocuments.net/reader030/viewer/2022040720/5e2c95b3399b0361fd676b5e/html5/thumbnails/50.jpg)
3147 patients (>24 H), 198 EU ICUs 1-15 May 2002 No Sepsis 1970 (60%), H mort 17% Sepsis 1177 (40%), H mort 36%
25%
![Page 51: Infezioni polmonari: gestione diversa per HAP & VAP · – PPI ? – Diuretics ? 3 sorelle ??? ... marmellata di albicocca) INFECTIONS & AMS in ICU ID in ICU ? INFECTIONS & AMS in](https://reader030.vdocuments.net/reader030/viewer/2022040720/5e2c95b3399b0361fd676b5e/html5/thumbnails/51.jpg)
Collaborative Italian Group
for Intensive Care Unit Vigilance
GiVITI
Project “Margherita”